Articles

Hoy en día la población de los países desarrollados tiene un promedio de vida de 80 años, durante esa vida gastamos aproximadamente el 30% de nuestra energía para proteger nuestro cuerpo contra factores nocivos. Los peligros ambientales, la tensión y la radiación causan cambios en la estructura de los genes, lo que, a su vez, acelera el envejecimiento y acorta nuestra esperanza de vida en un 30-40%. Los progresos científicos de la actualidad han hecho posible controlar el proceso de envejecimiento. Esto se basa en un sistema biorregulador operado por mediadores celulares llamados péptidos. Las funciones de los péptidos incluyen el intercambio...

Source: St. Petersburg Institute of Gerontology Introduction For many years a phenomenon of ageing had been studied within the framework of ethics and social issues. Only in the last century the society realized that a process of ageing should be studied from a different viewpoint, that is, as a special physiologic mechanism bearing a certain evolutionary significance. Ageing is the most complicate issue in medicine and biology. The process of ageing is a gradual involution of tissues and development of organism malfunctioning. Its symptoms appear already at the end of the reproductive period and become more pronounced with ageing. At...

Original, 2011 An interview with Vladimir Khackelevich Khavinson, the President of the European section of the International Association of Gerontology and Geriatrics (IAGG), an associate member of the Russian Ministry of Health, the Director of the St.Petersburg’s Institute of Bioregulation and Gerontology of the North Western Department of the Russian Academy of Medical Sciences, the Honoured Inventor of the Russian Federation, a Professor and a Doctor of Medical Science. Mr Khavinson, in our talks you mention that the species life span limit of a human is 110-120 years. Why a contemporary person who lives in the age of intensive economic...

From the evolution standpoint, modern humans have entered a stage of increased advanced aging as the proportion of people in older age groups continues to grow. The limit of human life expectancy is now being recorded at 110-120 years with a maximum reliable life expectancy going as high as 122 years. However, the main task of modern science is not to increase the human life span alone, but to increase the average human work/productivity period. Therefore, scientists are researching medications and other methods to increase human work productivity. The increase in vitality resource and increased working life span will enable...

Clinical study of Endoluten (neuroendocrine system) Clinical study of Cerluten (brain) Clinical study of Vladonix (immune system) Clinical study of Ventfort (blood vessels) Clinical study of Suprefort (pancreas) Clinical study of Svetinorm (liver) Clinical study of Sigumir (joints and bones) Clinical study of Pielotax (kidneys) Clinical study of Chitomur (bladder) Pinealon increases cell viability by suppression of free radical levels and activating proliferative processes. Peptide regulation of ageing Peptides of pineal gland and thymus prolong human life Effects of pineal peptide preparation Epithalamin on free-radical processes in humans and animals Gerontological aspects of genome peptide regulation Peptide Regulation of Aging: 35-Year Research Experience Regulatory Peptides...

Por años el Instituto de Biorregulación y Gerontología de San Petersburgo de la División Noreste de la Academia Rusa de Ciencias Médicas ha estado desarrollando un acercamiento especial a una nueva clase de medicación a base de péptidos. Como resultado del análisis de la secuencia amino-ácida de péptidos liberados de órganos y tejidos, se han desarrollado péptidos de cadena corta fisiológicamente activos, los que luego fueron definidos como una clase de citógenos, también conocida como péptidos sintetizados de cadena corta. Esta clase de productos farmacéuticos se caracteriza por una acción más rápida en comparación con los extractos: los efectos fisiológicos...